{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:32:59Z","timestamp":1789079579688,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1067\/mjd.2003.417","type":"journal-article","created":{"date-parts":[[2003,7,16]],"date-time":"2003-07-16T18:38:44Z","timestamp":1058380724000},"page":"79-82","source":"Crossref","is-referenced-by-count":18,"title":["The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis"],"prefix":"10.1067","volume":"49","author":[{"given":"Tamara Salam","family":"Housman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly G.","family":"Mellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Alan B.","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2003.417_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-4362.2000.00878.x","article-title":"New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care","volume":"39","author":"Feldman","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2003.417_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mjd.2001.117046","article-title":"Treatment of psoriasis, part 1: topical therapy and phototherapy","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.417_bib3","first-page":"581","article-title":"Patients with psoriasis and their compliance with medication","volume":"41","author":"Richards","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.417_bib4","doi-asserted-by":"crossref","first-page":"11c","DOI":"10.5070\/D39D81J8MF","article-title":"Skin cap: what have we learned, and when did we learn it?","volume":"3","author":"Smith","year":"1997","journal-title":"Dermatol Online J"},{"key":"10.1067\/mjd.2003.417_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0092-8674(89)90050-0","article-title":"Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor","volume":"57","author":"Danielsen","year":"1989","journal-title":"Cell"},{"key":"10.1067\/mjd.2003.417_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000018390","article-title":"Patient compliance and disease management in the treatment of psoriasis in the Netherlands","volume":"200","author":"Van de Kerkhof","year":"2000","journal-title":"Dermatology"},{"key":"10.1067\/mjd.2003.417_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(91)70069-E","article-title":"A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis","volume":"24","author":"Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2003.417_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-4362.2000.00986-4.x","article-title":"Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery","volume":"39","author":"Franz","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2003.417_bib9","first-page":"651","article-title":"Comprehensive dermatologic drug therapy","author":"Wolverton","year":"2001"},{"key":"10.1067\/mjd.2003.417_bib10","doi-asserted-by":"crossref","first-page":"11d","DOI":"10.5070\/D336091431","article-title":"Pustular psoriasis and hepatotoxicity associated with use of Skin Cap","volume":"3","author":"Tan","year":"1997","journal-title":"Dermatol Online J"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962203007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T08:51:47Z","timestamp":1704876707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962203007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S0190962203007734"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2003.417","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}